SLC18A1: A Protein Involved in Neurotransport and Disease Development

Target Name: SLC18A1

NCBI ID: G6570

SLC18A1: A Protein Involved in Neurotransport and Disease Development

SLC18A1 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and lungs. It is a member of the solute carrier family 18, which is a large family of transporters that play a crucial role in the transport of various molecules throughout the body. SLC18A1 is characterized by its ability to transport a wide variety of molecules, including amino acids, nucleotides, and other small molecules.

One of the unique features of SLC18A1 is its expression pattern. It is primarily expressed in the brain, where it is involved in the transport of various amino acids and other molecules. It is also expressed in other tissues, including the heart and lungs, where it is involved in the transport of nutrients and other molecules.

SLC18A1 is also known for its role in the regulation of various signaling pathways. It has been shown to be involved in the regulation of several signaling pathways, including the neurotransmitter signaling pathway and the cell signaling pathway.

SLC18A1 has also been shown to play a role in the development and progression of various diseases. For example, it has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It has also been shown to be involved in the development of cardiovascular diseases, such as heart failure and hypertension.

Due to its involvement in several important signaling pathways and its role in the development of various diseases, SLC18A1 has become a promising drug target. Researchers are currently working to develop new treatments for various diseases that are caused by SLC18A1.

In conclusion, SLC18A1 is a protein that is expressed in various tissues throughout the body and is involved in the transport of a wide variety of molecules. It is also known for its role in the regulation of various signaling pathways and its involvement in the development and progression of various diseases. As a result, SLC18A1 is a promising drug target for a variety of diseases.

Protein Name: Solute Carrier Family 18 Member A1

Functions: Electrogenic antiporter that exchanges one cationic monoamine with two intravesicular protons across the membrane of secretory and synaptic vesicles. Uses the electrochemical proton gradient established by the V-type proton-pump ATPase to accumulate high concentrations of monoamines inside the vesicles prior to their release via exocytosis. Transports catecholamines and indolamines with higher affinity for serotonin (PubMed:23337945, PubMed:8643547, PubMed:16326835). Regulates the transvesicular monoaminergic gradient that determines the quantal size. Mediates presynaptic monoaminergic vesicle transport in the amygdala and prefrontal brain regions related with emotion processing in response to environmental stimuli (PubMed:23337945)

More Common Targets